Overdoing it can occasionally lead to side effects like nerve irritation (with too much B6), skin flushing (from high-dose B3), or digestive upset

This stack is designed to support fat loss in a way that feels more metabolic than stimulant-driven. 1) Supports Fat Metabolism (AOD 9604) AOD 9604 is often used to support the bodys ability to: break down stored fat more effectively support lean tissue while dieting improve stuck progress when lifestyle habits are already in place 2) Supports Cellular Energy + Metabolic Flexibility (MOTS-c) MOTS-c is often chosen to support: mitochondrial energy production better fuel utilization (carbs/fats) improved metabolic efficiency and resilience 3) Supports Visceral Fat + Midsection Goals (Tesamorelin) Tesamorelin is often used to support: visceral fat reduction in certain individuals improved body composition over time metabolic support when stress, sleep, and hormones contribute to abdominal fat storage In simpler terms: AOD 9604 helps target fat metabolism, MOTS-c supports energy/efficiency, and Tesamorelin supports deeper midsection/visceral fat goals

Pregnant individuals, those with renal impairment, or patients in early GLP-1 dosing phases (first 4-8 weeks) should avoid fasting without explicit medical clearance
The difference between preclinical and human data matters enormously
A: The main advantage of a KLOW stacking guide is the potential for synergistic effects, where combining KLOW with other peptides amplifies or broadens its benefits beyond what individual compounds might achieve, leading to more profound research outcomes
aHR: 0.57, 95% CI: 0.510.64) (Table 2, Table S3-4)